Arkolith/Insider Trading/TARS/Form 4

Azamian Bobak R.

President/CEO and Board Chair, DirectorTarsus Pharmaceuticals, Inc. (TARS) · full profile →Form 4 · filed Jun 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$615K
Net Open-Market Flow
-$615K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Sell(S)5K$61.24$281K853K
Jun 17, 2026Sell(S)5K$61.81$335K848K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001827672-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML